{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T21:48:30Z","timestamp":1775771310484,"version":"3.50.1"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,7,26]]},"DOI":"10.18632\/oncotarget.9390","type":"journal-article","created":{"date-parts":[[2016,6,14]],"date-time":"2016-06-14T18:39:54Z","timestamp":1465929594000},"page":"46835-46847","source":"Crossref","is-referenced-by-count":11,"title":["Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL"],"prefix":"10.18632","volume":"7","author":[{"given":"Aviya","family":"Goldshtein","sequence":"first","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, The Biomedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shani Mistriel","family":"Zerbib","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, The Biomedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Omar","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, The Biomedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Cohen-Daniel","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, The Biomedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Popkin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Berger","sequence":"additional","affiliation":[{"name":"The Lautenberg Center for Immunology and Cancer Research, The Biomedical Research Institute Israel Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School Jerusalem, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"A","year":"2002","journal-title":"cancer cell"},{"issue":"5","key":"2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Hoelzer","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"3","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1084\/jem.20080134","article-title":"Delta-like 4 is indispensable in thymic environment specific for T cell development","volume":"205","author":"Habu","year":"2008","journal-title":"J Exp Med"},{"issue":"5","key":"4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ni1453","article-title":"Regulation of lymphocyte development by Notch signaling","volume":"8","author":"Honjo","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1074-7613(02)00330-8","article-title":"Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes","volume":"16","author":"Radtke","year":"2002","journal-title":"Immunity"},{"issue":"7","key":"6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S1471-4906(03)00141-8","article-title":"Regulation of quiescence in lymphocytes","volume":"24","author":"Fruman","year":"2003","journal-title":"Trends Immunol"},{"key":"7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-2164-10-261","article-title":"Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal","volume":"10","author":"Steffen","year":"2009","journal-title":"BMC Genomics"},{"issue":"3","key":"8","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1371\/journal.pbio.0040083","article-title":"A new description of cellular quiescence","volume":"4","author":"Roberts","year":"2006","journal-title":"PLoS Biol"},{"issue":"22","key":"9","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1073\/pnas.96.22.12691","article-title":"Activation changes the spectrum but not the diversity of genes expressed by T cells","volume":"96","author":"Marrack","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Gilliland","year":"2007","journal-title":"Cell"},{"issue":"2","key":"11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ni.1689","article-title":"Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor","volume":"10","author":"Hedrick","year":"2009","journal-title":"Nat Immunol"},{"issue":"3","key":"12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.immuni.2009.02.003","article-title":"An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance","volume":"30","author":"Li","year":"2009","journal-title":"Immunity"},{"issue":"5334","key":"13","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1126\/science.277.5334.1986","article-title":"LKLF: A transcriptional regulator of single-positive T cell quiescence and survival","volume":"277","author":"Leiden","year":"1997","journal-title":"Science"},{"issue":"12","key":"14","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni730","article-title":"Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells","volume":"2","author":"Boussiotis","year":"2001","journal-title":"Nat Immunol"},{"issue":"9","key":"15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ni.2068","article-title":"The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function","volume":"12","author":"Chi","year":"2011","journal-title":"Nat Immunol"},{"issue":"6","key":"16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ni.2034","article-title":"Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells","volume":"12","author":"Hu","year":"2011","journal-title":"Nat Immunol"},{"issue":"5","key":"17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(00)80663-9","article-title":"Schlafen, a new family of growth regulatory genes that affect thymocyte development","volume":"9","author":"Hedrick","year":"1998","journal-title":"Immunity"},{"issue":"10","key":"18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/intimm\/dxh155","article-title":"Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif","volume":"16","author":"Zerrahn","year":"2004","journal-title":"Int Immunol"},{"key":"19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2006.07.007","article-title":"The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions","volume":"180","author":"Leist","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"13","key":"20","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.molimm.2007.03.001","article-title":"Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation","volume":"44","author":"Kwon","year":"2007","journal-title":"Mol Immunol"},{"issue":"35","key":"21","doi-asserted-by":"crossref","first-page":"30723","DOI":"10.1074\/jbc.M500435200","article-title":"Schlafen-1 causes a cell cycle arrest by inhibiting induction of cyclin D1","volume":"280","author":"O'Neill","year":"2005","journal-title":"J Biol Chem"},{"issue":"12","key":"22","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.cellsig.2008.08.019","article-title":"RANKL-induced schlafen2 is a positive regulator of osteoclastogenesis","volume":"20","author":"Lee","year":"2008","journal-title":"Cell Signal"},{"issue":"2","key":"23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bcmd.2008.03.006","article-title":"Lack of reproducible growth inhibition by Schlafen1 and Schlafen2 in vitro","volume":"41","author":"Gonda","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ni.1847","article-title":"An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence","volume":"11","author":"Akira","year":"2010","journal-title":"Nat Immunol"},{"issue":"10","key":"25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrc1455","article-title":"Post-translational modification of p53 in tumorigenesis","volume":"4","author":"Dong","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"26","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrc864","article-title":"Live or let die: the cell's response to p53","volume":"2","author":"Lu","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"16","key":"27","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1158\/0008-5472.CAN-05-1664","article-title":"Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression","volume":"65","author":"Capobianco","year":"2005","journal-title":"Cancer Res"},{"issue":"11","key":"28","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.4049\/jimmunol.155.11.5455","article-title":"bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy","volume":"155","author":"Eisenberg","year":"1995","journal-title":"J Immunol"},{"issue":"7249","key":"29","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nature08020","article-title":"CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia","volume":"459","author":"Lipp","year":"2009","journal-title":"Nature"},{"issue":"1","key":"30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nm1524","article-title":"Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia","volume":"13","author":"Aifantis","year":"2007","journal-title":"Nat Med"},{"issue":"7","key":"31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ng1572","article-title":"Temporal dissection of p53 function in vitro and in vivo","volume":"37","author":"Evan","year":"2005","journal-title":"Nat Genet"},{"issue":"9617","key":"32","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Look","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"33","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Ferrando","year":"2012","journal-title":"J Clin Invest"},{"issue":"5","key":"34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nri2304","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma","volume":"8","author":"Buonamici","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"35","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1182\/blood.V84.9.3105.3105","article-title":"Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia","volume":"84","author":"Yu","year":"1994","journal-title":"Blood"},{"issue":"8","key":"36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM199708213370804","article-title":"Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma","volume":"337","author":"Hotta","year":"1997","journal-title":"N Engl J Med"},{"issue":"1","key":"37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/jpet.102.037192","article-title":"DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells","volume":"303","author":"Findley","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"38","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.leukres.2006.12.007","article-title":"Inactivation of p14ARF as a key event for the progression of adult T cell leukemia\/lymphoma","volume":"31","author":"Matsuyama","year":"2007","journal-title":"Leuk Res"},{"issue":"5","key":"39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ni.2012","article-title":"The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow","volume":"12","author":"Beutler","year":"2011","journal-title":"Nat Immunol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T22:06:40Z","timestamp":1692396400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":39,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016,7,26]]}},"alternative-id":["9390","27206675"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9390","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}